Pliant Therapeutics, Inc. (PLRX)

NMS – Real Time Price. Currency in USD

1.18

-0.02 (-1.67%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

10M

Cost of goods sold

-2M

-4M

Gross Profit

-2M

-261K

Operating expenses (excl. COGS)

-148M

-226M

-184M

-133M

Operating Income

-150M

-228M

-184M

-127M

Non-operating income, total

729K

18M

23M

Pretax income

-149M

-210M

-161M

-123M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-149M

-210M

-161M

-123M

Pliant Therapeutics, Inc. (PLRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pliant Therapeutics, Inc. (PLRX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Pliant Therapeutics, Inc. (PLRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pliant Therapeutics, Inc. (PLRX)

Income Statement (Annual)

Income Statement (Annual)